US Roadshow Presentation Slides
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
ASX: HIQ
HITIQ LTD 4/38-42 White Street, South Melbourne, VIC 3205
ACN 609 543 213 investors@hitiq.com
hitiq.com
15 October 2025
US Roadshow – Presentation Slides
HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a leader in concussion management
technology, advises Executive Chair, Earl Eddings, and Non-Executive Director Matthew
Clayworth will be undertaking a roadshow to potential investors and customers in the US this
week.
Copies of the slides to be presented are attached.
For further information, please contact:
Shareholders: investors@hitiq.com
The release of this announcement was authorised by the Board.
– END –
End-to-End Brain-Health
Surveillance & Management
Private and confidential, commercial
in confidence
Concussion Management System
Turning head-impact data into safer decisions
October 2025
Earl Eddings- Executive Chairman
Email: earl@hitiq.co
Disclaimer
This presentation is not an offer for financial products in any jurisdiction or a financial product recommendation. The information in this
presentation is an overview and does not contain all information necessary for investment decisions. In making investment decisions in
connection with any acquisition of financial products, investors should rely on their own examination of HITIQ Limited (“HITIQ , “HIQ” or the
“Company”) and consult with their own legal, tax, business and/or financial advisers.
The information contained in this presentation has been prepared in good faith by the Company. However, no representation or warranty
expressed or implied is made as to the accuracy, correctness, completeness or adequacy of any statements, estimates, opinions or other
information contained in this presentation. To the maximum extent permitted by law, HITIQ, its directors, officers, employees and agents
disclaim liability for any loss or damage which may be suffered by any person through the use or reliance on anything contained in or omitted
in this presentation.
Certain information in this presentation refers to the intentions of HITIQ, but these are not intended to be forecasts, forward looking
statements or statements about future matters for the purposes of the Corporations Act or any other applicable law. The occurrence of
events in the future are subject to risks, uncertainties and other factors that may cause the Company’s actual results, performance or
achievements to differ from those referred to in this presentation. Accordingly, HITIQ, its directors, officers, employees and agents do not
give any assurance or guarantees.
1
Executive Summary
1. What We Do –
Brain-Health
Surveillance
• Problem: Head impacts are
often missed in the moment;
coaches/parents lack
auditable return-to-play
workflows.
• Solution: Boil-and-bite smart
mouthguard + app +
telehealth that identifies head
impacts, flags risk, and
manages recovery with a
trackable incident history.
• Guardrail: Brain-health
surveillance & risk mitigation
— not prevention or
diagnosis.
2. Why Now & Why Us
The Reset + Proof
• Reset: New leadership;
consumer product live;
scalable sensor board (volume
manufacturing).Immediate fit:
Boil-and-bite = instant
activation (no lab wait) →
faster adoption & reviews.
• Independent validation: Lab
(Virginia Tech), Field (70k+
video-verified impacts),
Biomarkers (Monash).
• Defensibility: Retail-grade
engineering, largest labelled
dataset, privacy-by-design,
and insider understanding of
sports procurement.
3. US Go-to-Market
Consumer →
Schools/Clubs →
Leagues
• Ladder: Consumer retail & e-
comm → Schools & clubs
(coach portal,
consent/telehealth) → League
pilots (off-season) → multi-
year agreements.
• Who buys & why:
Parents/athletes (safety,
incident history) •
Coaches/ADs (workflow,
auditability) • Leagues
(governance/liability optics).
• Signals today: In-market
usage, retail onboarding,
repeat use, ambassador
momentum (forward-looking
items subject to contract).
4. Market & Plan
Multi-Billion US
Opportunity, Clear
Milestones
• Opportunity: Multi-billion US
market for devices and
recurring software.
• Use of funds (18–24 mo): US
GTM, manufacturing scale &
COGS, product & data
(coach/league tools,
consent/telehealth), evidence
publications.
• 12–18 mo milestones: Scaled
consumer & schools/clubs,
signed league pilots, Stage-2
COGS, renewal uplift, public
evidence releases.
Data flywheel advantage in a multi-billion US sports health market.
2
The Problem: head impacts are missed, decisions lack objective data
The Problem: A Crisis in Grassroots Sports
• Fear of concussion is driving declines in youth sport participation. [4][5]
• 100,000+ concussions annually in Australia; up to 70% go undetected. [1]
• Parents and clubs are losing confidence → safety, participation, and liability
pressures. [6][7]
Our Solution: Democratizing Concussion Care
• PROTEQT delivers elite-grade head-impact identification and management
workflow to every level of sport—combining advanced sensors, real-time
analytics, and telehealth to make head-impact events visible, auditable, and
actionable. [8][9]
3
Why Now? scalable tech, consumer go-live, and policy pressure
1. Breakthrough Innovation
Enabling off-the-shelf
Scalability
Streamlined Sensor board built into Global
mouthguard leader’s Shock Doctor EasyFit
(Boil & Bite) mouthguard
2. Consumer Product Just
Launched
PROTEQT Now in market. Additionally,
elite appetite is growing — we have
experience to re-enter pro tiers.
3. Policy/Liability Awareness
is Rising
stakeholders need objective, auditable
workflows.
Sports procurement is seasonal and multi-stakeholder. Our plan begins consumer/grassroots first where adoption cycles are shortest, then
leverages data & trust to enter leagues
4
Product Snapshot
1. Detect
Embedded sensors in the Shock Doctor
PROTEQT mouthguard measure linear and
rotational forces in real time, capturing
critical data often missed on the field.
2. Assess
Impact data is automatically analysed in
the PROTEQT app, flagging concussion
risk, tracking symptoms, and building a
complete incident record for coaches,
parents, and clinicians.
3. Manage
Seamless telehealth integration
enables guided recovery and return-
to-play, closing the loop from on-field
events to medical care.
Secure, Scalable Analytics – powering athlete, club & industry insights
How works
World first, end-to-end concussion management solution, empowering athletes to play with confidence and giving parents peace of mind.
5
US Market + Global Growth Opportunity
Single PROTEQT Purchase
TAM~$5.0B — pricing $250 device. [13][14][15][16][17]
Annual Ongoing Subscription
TAM ~$2.1B/yr — pricing $100 ARPU. [13][16][17]
Global growth
TAM~$12.6B devices + ~$5.3B/yr subscriptions potential
Scale beyond the US.
• Priority regions: UK, AU, JP, NZ, localized via country participation datasets.
[18][19][23][24][25]
US 5-Year Modelling (100k Baseline units per year)
≈ $198.2M
• 100k units/yr): $250 includes Year-1 software; $100/yr renewals
at 85% renewal.
• Yr1–Yr5: $25.0M, $33.5M, $40.7M, $46.9M, $52.1M
6
Validation: Lab, Field, Biomarkers, Battle-tested tech
PROTEQT technology was forged and battle-tested in the arena of professional collision sports globally.
Lab Validation
• Independently tested at Virginia
Tech Helmet Lab. [8]
• Exceeded validation thresholds
across all metrics (PLA, PRV,
PRA). [8]
Field Validation
• Proven reliable in live gameplay
with video-verified ground truth.
[8][10]
• 93.6% sensitivity detecting head
impacts. [8]
• 98.3% accuracy (PPV) during
gameplay. [8]
Biomarker Validation
• Monash AFL/AFLW studies: high
sensitivity, low false positives. [9]
• Linked measured impact exposure
to brain-injury biomarkers,
confirming medical relevance. [9]
Battle Tested in the
Pros. Proven At Scale
• 70,000+ video-verified head
impacts assessed across
codes.
• Trusted by elite programs (e.g.,
AFL, Monash, Virginia Tech).
[8][9][10]
7
The MOAT
Exclusive
Hardware
Proprietary
Data
Integrated
Software
✓ Exclusive global
partnership with Shock
Doctor.
✓ Integrated workflow:
hardware +
software +
SCAT6/DSI
telehealth.
✓ Proprietary datasets
= clinical flywheel.
Only scalable boil-and-bite at
volume → immediate use vs
custom-lab weeks
A defensible end-to-end system: exclusive hardware + proprietary data + integrated software at retail scale
8
Defensible Competitive Advantage
Competitor Market reality
• Two players: HITIQ (boil-and-bite; immediate fit; scalable) vs Prevent
(custom-lab; multi-week workflow).[12]
1. Proprietary
Sensor Platform
2. Data Network
Effect
3. Full-Stack
Ecosystem
4. Sticky and
Scalable
5. Positioned to
Lead a $12.6B
Market
Patented, in-mouth technology
validated in elite programs
captures granular, real-time
impact data that competitors
cannot easily replicate.
With 70,000+ verified
impacts and counting,
PROTEQT holds one of the
world’s largest proprietary
concussion datasets. Every
new user strengthens our
insights and deepens our
structural advantage.
By integrating hardware,
analytics, clinical workflows,
and telehealth, PROTEQT
delivers a complete solution
where competitors offer only
single-point tools.
Once deployed athletes,
clubs and schools rely on
longitudinal data and
recovery tools —
embedding PROTEQT into
their workflows and raising
switching barriers.
Combining device revenue
with recurring data and
telehealth services, PROTEQT
is positioned as the trusted
category leader as regulation,
awareness, and liability
pressures rise.
Implications
• First to mass adoption wins the data flywheel → better models → better UX
→ more league leverage.
9
Activation to Adoption: US GTM & Proof
1. Why now
• Sport is hard to sell into
(seasonality, multi-stakeholder
approvals, risk-averse) — we’re
insiders, not outsiders.
• Boil-and-bite = immediate
activation → real reviews →
grassroots proof → leverage up
to leagues.
• Now vs before: scalable sensor
board; consumer product live;
elite appetite returning;
privacy/governance built-in.[12]
2. US GTM motion
• Consumer retail & e-comm —
instant fit, UGC, fast feedback
loops.
• Schools & clubs — packs,
coach portal, telehealth
workflow, auditable incident
history.
• League pilots (off-season) —
procurement-aligned trials;
dashboards; data-driven ROI →
multi-year agreements.
3. Proof so far
• Consumer product launched and in
market across multiple regions.
• Retail onboarding progressing;
channel partners ready for scale.
• Independent validation complete:
lab (Virginia Tech), field (video-
verified), biomarkers (Monash).
[8][9]
4. Adoption signals
• Positive early adoption in
consumer & grassroots
(schools/clubs) with repeat usage
and strong feedback.
• Frictionless fit accelerates time-
to-value vs custom workflows.
[12]
• Ambassador & content building
awareness and trust. [21]
Cracking sport with a US-first playbook: instant boil-and-bite activation → grassroots proof → league leverage.
10
Roadmap, Revenue Mix & Use of Funds
1. Sequencing
(procurement-aware; US
pull-forward option)
• UK hard launch: Sep ’25
• AU/NZ: Feb ’26
• North America: Feb ’27
(option: pull forward late
FY26 with incremental
capital).
• Match code calendars;
sell off-season; show live
user data, not promises.
2. Revenue mix
path
• Hardware ($250) seeds
users and incident history.
• Software ($100/yr)
compounds via renewals;
margin improves as mix
shifts.
• COGS step-down with
Stage-2 manufacturing.
3. Use of funds (18–24
months)
• US GTM (consumer
marketing, retail
enablement, school/club
sales pods, league BD).
• Manufacturing scale &
COGS (tooling, yields, QA).
• Product & data (coach
portal, league dashboards,
consent/privacy, telehealth).
• Clinical & regulatory (US-
centric evidence
publications). [8][9]
4. 12–18 month
milestones
• Consumer channels
scaled
• School/club footprint
• signed league pilots
• Stage-2 COGS
• Renewal benchmark
• Evidence publications.
We’ll drive US-first growth by seeding users with hardware, compounding high-margin subscriptions, and deploying funding into GTM, manufacturing scale,
product/data, and clinical proof to deliver scaled consumer & schools/clubs, signed league pilots, Stage-2 COGS, and renewal uplift
11
Candid Context & Risk Mitigation
Candid context
• ~10 years in market: publicly listed; leadership change
complete.
• Past constraints: no consumer product and non-scalable
workflow — now fixed.
• Focused on brain-health surveillance & risk mitigation (no
prevention/diagnosis).
Risks & mitigations
• League procurement cycles → beachhead in consumer/schools;
sell off-season; pre-commit pilots.
• Behaviour change & education → coach/parent toolkits; telehealth
workflow; ambassadors. [21]
• Category noise → independent lab + field + biomarker validation;
public data releases. [8][9][10]
• Hardware margins → Stage-2 manufacturing; software mix shift.
Youth privacy → privacy-by-design; consent flows; school/league
protocols.
We’ve reset the company (new leadership, scalable consumer product) and are now executing a US-first brain-health surveillance strategy—driving off-season
league pilots, education/telehealth adoption, a steady validation cadence, Stage-2 COGS + software mix improvements, and privacy-by-design going forward.
Board & Management
Execution is about people. We have experienced leadership, global expansion capability, and governance that reduces execution risk
Damien Hawes
Chief Commercial Officer
• Former Chief Commercial
Officer Catapult (ASX:
CAT), Head of League
Wide and Media
Partnerships & Commercial
Director of GPSports
Systems (acquired by
Catapult in 2014)
Tom Christian
Head of Product
• Canberra Raiders:
Managed athlete
performance and health
Technology Lead and
Sports
Scientist/Physiotherapist.
• Sports Tech Expert:
background in technical
support and management
for companies like
Catapult Sports and
GPSports Systems.
Andrew Hart
Chief Financial Officer
• Experienced CFO with a
strong track record of
building inclusive teams,
establishing scalable
processes and delivering
exceptional business
performance
Chris Davis
Chief Marketing Officer
• Former Head of Growth of
the A-Leagues, Digital
Sales at Optus Sport
• 10 years consulting,
designing and delivering
growth marketing
strategies
Yohan Jayasinghe
Head of Production
• Expertise in production,
engineering, and
operations.
• Instrumental in developing
and producing HITIQ’s
hardware.
• Vast experience at
delivering engineering
solutions from design to
deployment.
Mikayla Winfield-Smith
Customer Support Specialist
• Key member of HITIQ’s
customer support team,
specialising in client service
and technical assistance.
• Enhances user satisfaction and
drives operational excellence
through a collaborative
approach.
Tash Reeve
Community Activations
Coordinator
• Supports HITIQ’s community
sports initiatives,
coordinating activations,
events, and outreach with
local clubs and players.
• Brings enthusiasm and
strong organisational skills
to enhance delivery of
grassroots projects and
community impact.
Earl Eddings
Executive Chairman
• Former Chair of Cricket Australia and Director of
the International Cricket Council
• Non-Executive Director of Sports Tech Company
MSL Solutions
• FGIA, GAICD, Grad.Dip Risk Management,
B.A.S (PE)
Jennifer Tucker
Non-Executive Director
• Experienced executive and director in the
consumer products and health sectors.
• Former Director of Merchandise, Bunnings
and Executive General Manager, Yates
(DuluxGroup).
• Non-Executive Director of National Heart
Foundation, CAD Frontiers and Cranky
Health.
Phil Carulli
Non-Executive Chairman
• Chartered Accountant and Managing
Director of Optima Partners
• HITIQ Non-Executive Director and CFO
since August 2018
• Non-Executive Director of Soar-Earth
Limited
Matthew Clayworth
Non-Executive Director
• Senior Investment Advisor at Wilson’s
Advisory
• Representative for Harmil Angel
Investments
• Previously Vice President, Morgan Stanley
James Barrie
Non-Executive Director
• Professional Company Secretary and Non-
Executive Director
• Founder of Fernville Group
• Range of senior executive positions in
ASX20, ASX100, microcap.
Board
Management 12
Thank You
Earl Eddings- Executive Chairman
Email: earl@hitiq.co
Address: Unit 4/38-42 White Street,
South Melbourne. 3205,
Victoria
Share your feedback
Discover